The I.S.I.S. Difference |
|
Key Client Benefits |
| |
|
|
Quality of Primary Sources
Proprietary database of pre-qualified, well-cultivated contacts in 20 countries, including scientists, MDs, industry executives, nurses, regulators, analysts and other experts. |
|
Rapid turnaround of ad hoc requests, including in-depth interviews, fully triangulated expert insights, authoritative analysis and recommendations |
| |
|
|
| |
|
|
Expert Interviewers
Peer-to-peer interviews and conference coverage by highly-qualified professionals selected for each project from a multi-disciplinary team |
|
Interviewing by MD, PhD, and MBA-level CI investigators yields a high degree of confidence about timing and outcome of anticipated events |
| |
|
|
| |
|
|
Focus on Healthcare
Specialists in clinical, regulatory and commercial CI in 12 therapeutic areas |
|
Solid understanding of current and future market drivers and dynamics |
| |
|
|
| |
|
|
History of Superior Results
90% of CI assignments come from existing clients, which on average have been with us for 12 years – many since 1992 |
|
Long-term relationships empower us to anticipate client needs and become their eyes and ears in the marketplace |
| |
|
|
| |
|
|
Proven Methodologies
Effective, flexible and ethical CI methodologies, quality control and execution of global projects |
|
High ROI resulting from a high degree of confidence in strategic and tactical decision support outcomes |
| |
|
|
| |
|
|
Actionable Results
The level of analysis is precisely matched with client needs from plain Q&A to complex action/impact analysis |
|
High-confidence findings that mesh tightly with clients’ decision support requirements |
| |
|
|
| |
|
|
Protection of Intellectual Assets
Proven data leakage assessments and counter-intelligence mechanisms protect strategic and sensitive data |
|
Substantially reduced risk of leakage and potentially huge savings in planned or recently completed R&D |
